CORZ
CORZ
Core Scientific, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81.1M ▲ | $69.22M ▲ | $-146.66M ▲ | -180.83% ▲ | $-0.46 ▼ | $-127.46M ▼ |
| Q2-2025 | $78.63M ▼ | $31.31M ▼ | $-936.8M ▼ | -1.19K% ▼ | $-0.04 ▼ | $-634K ▲ |
| Q1-2025 | $79.53M ▼ | $50.81M ▲ | $580.69M ▲ | 730.2% ▲ | $1.44 ▲ | $-20.18M ▲ |
| Q4-2024 | $94.92M ▼ | $44.55M ▲ | $-265.54M ▲ | -279.74% ▲ | $-0.6 ▲ | $-234.88M ▲ |
| Q3-2024 | $95.35M | $41.06M | $-455.26M | -477.44% | $-1.56 | $-418.31M |
What's going well?
Revenue is holding steady and the net loss is much smaller than last quarter, mainly thanks to a big boost from 'other' income. No interest expense means the company isn't weighed down by debt.
What's concerning?
Core operating losses are growing fast, costs are rising much faster than sales, and margins are shrinking. The improvement in net loss is mostly due to non-operating items, not better business performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $453.44M ▼ | $2.3B ▲ | $3.42B ▲ | $-1.13B ▼ |
| Q2-2025 | $581.35M ▼ | $1.98B ▲ | $3.04B ▲ | $-1.06B ▼ |
| Q1-2025 | $697.94M ▼ | $1.63B ▲ | $1.81B ▼ | $-181.51M ▲ |
| Q4-2024 | $836.2M ▲ | $1.6B ▲ | $2.42B ▲ | $-820.18M ▼ |
| Q3-2024 | $253.02M | $921.85M | $1.65B | $-729.39M |
What's financially strong about this company?
The company has a solid base of physical assets and no risky goodwill or intangibles. Current assets still cover short-term bills, and deferred revenue provides some cash cushion.
What are the financial risks or weaknesses?
Negative equity, shrinking cash, and a long history of losses are major red flags. Heavy debt and no shareholder cushion mean the company is financially fragile.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-146.66M ▲ | $131.78M ▲ | $-254.36M ▼ | $-5.32M ▲ | $-127.9M ▼ | $-122.84M ▼ |
| Q2-2025 | $-936.8M ▼ | $34M ▲ | $-119.61M ▼ | $-31.77M ▼ | $-117.38M ▲ | $-87.28M ▲ |
| Q1-2025 | $580.69M ▲ | $-40.6M ▼ | $-93.46M ▼ | $-4.2M ▼ | $-138.25M ▼ | $-129.02M ▼ |
| Q4-2024 | $-184.79M ▲ | $13.8M ▲ | $-28.8M ▲ | $598.17M ▲ | $583.18M ▲ | $-14.95M ▲ |
| Q3-2024 | $-455.26M | $5.71M | $-31.24M | $182.22M | $156.7M | $-25.34M |
What's strong about this company's cash flow?
Operating cash flow improved dramatically to $132 million, showing the core business can generate cash. Net losses are mostly accounting, not real cash burn.
What are the cash flow concerns?
Free cash flow is deeply negative due to heavy investments, and cash reserves are shrinking quickly. The boost from working capital is likely temporary, and ongoing cash burn could become a problem.
Revenue by Products
| Product | Q2-2023 | Q3-2023 | Q4-2023 | Q1-2024 |
|---|---|---|---|---|
Digital Asset Mining Service | $0 ▲ | $80.00M ▲ | $210.00M ▲ | $150.00M ▼ |
Hosting Service | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Equipment Sales | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q1 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Core Scientific, Inc.'s financial evolution and strategic trajectory over the past five years.
Core Scientific’s key strengths include a large and strategically located power and data center footprint, operational experience with high-density and energy-intensive computing, and proprietary management software that can scale across vast fleets of devices. The recent improvement in liquidity gives it short-term breathing room, and the pivot toward AI and HPC hosting positions it in a segment where demand is robust. Its ability to repurpose existing facilities offers a structural time-to-market advantage that many competitors lack.
Major risks cluster around financial fragility and execution. The company has a history of very large losses, negative equity, and dependence on external financing, all of which raise questions about long-term solvency if conditions worsen. Free cash flow has been negative in most years, and leverage is high. Strategically, it faces the twin challenges of crypto market volatility and intense competition in AI infrastructure, combined with customer concentration and ongoing heavy capital needs. Any misstep in scaling HPC, securing diversified contracts, or controlling costs could quickly strain its balance sheet.
The outlook is highly mixed and carries substantial uncertainty. On one hand, Core Scientific owns valuable assets and capabilities that are well aligned with rising demand for AI and HPC computing, and it has shown a willingness to innovate and reject deals it views as undervaluing its standalone potential. On the other hand, its financial track record is weak, its capital structure is stressed, and its business remains exposed to cyclical and volatile markets. Future performance will largely depend on how quickly and profitably it can grow its HPC and hosting operations, improve margin discipline, and convert its strengthened liquidity into a sustainable, self-funding business model.
About Core Scientific, Inc.
https://www.corescientific.comCore Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81.1M ▲ | $69.22M ▲ | $-146.66M ▲ | -180.83% ▲ | $-0.46 ▼ | $-127.46M ▼ |
| Q2-2025 | $78.63M ▼ | $31.31M ▼ | $-936.8M ▼ | -1.19K% ▼ | $-0.04 ▼ | $-634K ▲ |
| Q1-2025 | $79.53M ▼ | $50.81M ▲ | $580.69M ▲ | 730.2% ▲ | $1.44 ▲ | $-20.18M ▲ |
| Q4-2024 | $94.92M ▼ | $44.55M ▲ | $-265.54M ▲ | -279.74% ▲ | $-0.6 ▲ | $-234.88M ▲ |
| Q3-2024 | $95.35M | $41.06M | $-455.26M | -477.44% | $-1.56 | $-418.31M |
What's going well?
Revenue is holding steady and the net loss is much smaller than last quarter, mainly thanks to a big boost from 'other' income. No interest expense means the company isn't weighed down by debt.
What's concerning?
Core operating losses are growing fast, costs are rising much faster than sales, and margins are shrinking. The improvement in net loss is mostly due to non-operating items, not better business performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $453.44M ▼ | $2.3B ▲ | $3.42B ▲ | $-1.13B ▼ |
| Q2-2025 | $581.35M ▼ | $1.98B ▲ | $3.04B ▲ | $-1.06B ▼ |
| Q1-2025 | $697.94M ▼ | $1.63B ▲ | $1.81B ▼ | $-181.51M ▲ |
| Q4-2024 | $836.2M ▲ | $1.6B ▲ | $2.42B ▲ | $-820.18M ▼ |
| Q3-2024 | $253.02M | $921.85M | $1.65B | $-729.39M |
What's financially strong about this company?
The company has a solid base of physical assets and no risky goodwill or intangibles. Current assets still cover short-term bills, and deferred revenue provides some cash cushion.
What are the financial risks or weaknesses?
Negative equity, shrinking cash, and a long history of losses are major red flags. Heavy debt and no shareholder cushion mean the company is financially fragile.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-146.66M ▲ | $131.78M ▲ | $-254.36M ▼ | $-5.32M ▲ | $-127.9M ▼ | $-122.84M ▼ |
| Q2-2025 | $-936.8M ▼ | $34M ▲ | $-119.61M ▼ | $-31.77M ▼ | $-117.38M ▲ | $-87.28M ▲ |
| Q1-2025 | $580.69M ▲ | $-40.6M ▼ | $-93.46M ▼ | $-4.2M ▼ | $-138.25M ▼ | $-129.02M ▼ |
| Q4-2024 | $-184.79M ▲ | $13.8M ▲ | $-28.8M ▲ | $598.17M ▲ | $583.18M ▲ | $-14.95M ▲ |
| Q3-2024 | $-455.26M | $5.71M | $-31.24M | $182.22M | $156.7M | $-25.34M |
What's strong about this company's cash flow?
Operating cash flow improved dramatically to $132 million, showing the core business can generate cash. Net losses are mostly accounting, not real cash burn.
What are the cash flow concerns?
Free cash flow is deeply negative due to heavy investments, and cash reserves are shrinking quickly. The boost from working capital is likely temporary, and ongoing cash burn could become a problem.
Revenue by Products
| Product | Q2-2023 | Q3-2023 | Q4-2023 | Q1-2024 |
|---|---|---|---|---|
Digital Asset Mining Service | $0 ▲ | $80.00M ▲ | $210.00M ▲ | $150.00M ▼ |
Hosting Service | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Equipment Sales | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q1 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Core Scientific, Inc.'s financial evolution and strategic trajectory over the past five years.
Core Scientific’s key strengths include a large and strategically located power and data center footprint, operational experience with high-density and energy-intensive computing, and proprietary management software that can scale across vast fleets of devices. The recent improvement in liquidity gives it short-term breathing room, and the pivot toward AI and HPC hosting positions it in a segment where demand is robust. Its ability to repurpose existing facilities offers a structural time-to-market advantage that many competitors lack.
Major risks cluster around financial fragility and execution. The company has a history of very large losses, negative equity, and dependence on external financing, all of which raise questions about long-term solvency if conditions worsen. Free cash flow has been negative in most years, and leverage is high. Strategically, it faces the twin challenges of crypto market volatility and intense competition in AI infrastructure, combined with customer concentration and ongoing heavy capital needs. Any misstep in scaling HPC, securing diversified contracts, or controlling costs could quickly strain its balance sheet.
The outlook is highly mixed and carries substantial uncertainty. On one hand, Core Scientific owns valuable assets and capabilities that are well aligned with rising demand for AI and HPC computing, and it has shown a willingness to innovate and reject deals it views as undervaluing its standalone potential. On the other hand, its financial track record is weak, its capital structure is stressed, and its business remains exposed to cyclical and volatile markets. Future performance will largely depend on how quickly and profitably it can grow its HPC and hosting operations, improve margin discipline, and convert its strengthened liquidity into a sustainable, self-funding business model.

CEO
Adam Sullivan
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 157
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Keefe, Bruyette & Woods
Outperform
BTIG
Buy
Citizens
Market Outperform
Bernstein
Outperform
Macquarie
Outperform
Clear Street
Buy
Grade Summary
Showing Top 6 of 15
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:33.96M
Value:$576.31M
SITUATIONAL AWARENESS LP
Shares:28.76M
Value:$488M
BLACKROCK, INC.
Shares:26.41M
Value:$448.1M
Summary
Showing Top 3 of 456

